A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal Cancers

Marwan Fakih, Toshihiko Doi, Anthony Tolcher, David Hong, Jeanne Tie, Wells Messersmith, Takafumi Koyama, Lee Rosen, Joana Borlido, Michael A. Damore, Maria Delioukina, Ioanna Cheronis, Lee Noel. Clark, Marzieh Golmakani, Amy Jackson-Fisher, Szu-Yu Tang, Cathy C. Guo, Edmund J. Keliher, Kevin Maresca, Neil H. Segal

Open source

DOI: 10.1158/2767-9764.crc-26-0101
Published: 2026-09-04
Container: Cancer Research Communications
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0101,
  title = {A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal Cancers},
  author = {Marwan Fakih and Toshihiko Doi and Anthony Tolcher and David Hong and Jeanne Tie and Wells Messersmith and Takafumi Koyama and Lee Rosen and Joana Borlido and Michael A. Damore and Maria Delioukina and Ioanna Cheronis and Lee Noel. Clark and Marzieh Golmakani and Amy Jackson-Fisher and Szu-Yu Tang and Cathy C. Guo and Edmund J. Keliher and Kevin Maresca and Neil H. Segal},
  year = {2026},
  journal = {Cancer Research Communications},
  doi = {10.1158/2767-9764.crc-26-0101},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0101}
}

RIS

TY  - JOUR
TI  - A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal Cancers
AU  - Marwan Fakih
AU  - Toshihiko Doi
AU  - Anthony Tolcher
AU  - David Hong
AU  - Jeanne Tie
AU  - Wells Messersmith
AU  - Takafumi Koyama
AU  - Lee Rosen
AU  - Joana Borlido
AU  - Michael A. Damore
AU  - Maria Delioukina
AU  - Ioanna Cheronis
AU  - Lee Noel. Clark
AU  - Marzieh Golmakani
AU  - Amy Jackson-Fisher
AU  - Szu-Yu Tang
AU  - Cathy C. Guo
AU  - Edmund J. Keliher
AU  - Kevin Maresca
AU  - Neil H. Segal
PY  - 2026
JO  - Cancer Research Communications
DO  - 10.1158/2767-9764.crc-26-0101
UR  - https://doi.org/10.1158/2767-9764.crc-26-0101
ER  -

APA

Fakih, M., Doi, T., Tolcher, A., Hong, D., Tie, J., Messersmith, W., Koyama, T., Rosen, L., Borlido, J., Damore, M. A., Delioukina, M., Cheronis, I., Clark, L. N., Golmakani, M., Jackson-Fisher, A., Tang, S., Guo, C. C., Keliher, E. J., Maresca, K., & Segal, N. H. (2026). A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal Cancers. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-26-0101

Source records

crossref · retrieved 2026-09-25T19:41:59.177Z